secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001140361-26-007478
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotechnology receives Nasdaq bid price deficiency notice; 180 days to cure
-------------------------------------------------------------------------------

- Stock closed below $1.00 for 30 consecutive business days, triggering Nasdaq Listing Rule 5550(a)(2) deficiency.
- Company has 180 calendar days, until August 24, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by deadline, company may seek a second 180-day period if it meets other listing standards.
- Potential remedies include a reverse stock split; delisting could occur if compliance is not achieved.
- Common stock continues trading on Nasdaq under symbol PDSB with no immediate impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126007478/0001140361-26-007478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126007478/ef20067044_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-007478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer